ClinicalTrials.gg
RecruitingNCT05488093MOUV-GOPROUpdated Apr 14, 2026

Evaluation of Mobility in Subjects With Severe Knee Osteoarthritis Who Are to Undergo Total Knee Replacement

An interventional study of X-sens sensor in Knee Osteoarthritis, sponsored by University Hospital, Montpellier. Recruiting at 1 site in France. Open to participants aged 60 Years and older. Per ClinicalTrials.gov, last updated 2026-04-14.

Sponsored by University Hospital, Montpellier · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Started Mar 2023; still recruiting 3 years 7 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Not applicable
Ages
60 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 124 studies in Osteoarthritis, Knee with a site in France — 23 open to participants now, 33 under way, 1 of them phase 3. Osteoarthritis, Knee · France.

Planned enrollment
78th of 86
20 · median 106
Started
2023
with 10 others
No phase
58 of 124
13 open now
Primary completion
2027-03
later than 17 of 32 live
Registered
93rd of 124
by date

Among the 124 studies in Osteoarthritis, Knee with a site in France, this one is the 78th largest by planned enrollment of the 86 interventional ones that give a count, is one of 11 that started in 2023, is one of 58 with no phase, reaches primary completion later than 17 of the 32 other live ones, and was the 93rd registered.

Osteoarthritis, Knee

3,297 studies on the registry are indexed under Osteoarthritis, Knee; 623 are open to participants now.

Browse Osteoarthritis, Knee studies →

Open to participants now

23 of the 124 studies in Osteoarthritis, Knee with a site in France are open now. Recruiting first, the newest first:

17 more — sign in →

All 23 open studies →

A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →

Who these studies take

Of the 384 Osteoarthritis, Knee studies recruiting now, 178 (46%) set no upper age limit and 113 (29%) stop at 75 or younger; 19 take children under 18; 39 take healthy volunteers.

This study: 60 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 124 studies in Osteoarthritis, Knee with a site in France, or all of them as a file.
02

Study summary

Osteoarthritis (OA) is the most common joint disease. It is characterized by a progressive destruction of all the components of the joint, especially the cartilage. This leads to pain, loss of mobility and can be a major handicap for some patients.

Gonarthrosis, or osteoarthritis of the knee, affects 30% of people between the ages of 65 and 75 and is one of the most disabling conditions. In the final stage, the only therapeutic option to relieve patients is to replace the joint with a total knee prosthesis.

Thanks to the contribution of an evaluation technique based on inertial sensors (X-SENS device), our objective is to better evaluate and understand the movement deficit in knee OA subjects.

The hypothesis is that, thanks to the contribution of a technique based on inertial sensors (X-SENS), the investigators can better evaluate the movement deficit of knee OA subjects. The goal is to propose specific, rapid telekinetic biomarkers, allowing a better evaluation of functional improvements following therapeutic interventions, such as a total knee replacement.

Read the detailed description

Osteoarthritis is the most common joint disease. It is characterized by a progressive destruction of all the components of the joint, especially the cartilage. This leads to pain, loss of mobility and can be a major disability for some patients.

Knee osteoarthritis affects 30% of people between the ages of 65 and 75 and is one of the most disabling conditions. In the final stage, the only therapeutic option to relieve patients is to replace the joint with a total knee prosthesis.

Previous research has shown that self-administered questionnaires to assess the benefits of management in knee osteoarthritis were limited and didn't accurately describe recovery from total knee replacement.

Functional performance tests can objectively capture a patient's mobility, but each test only approaches a small number of parameters involved in movement, which is not representative of the subject's experiences in daily life (walking, going up/down stairs, getting up from a chair).

In knee OA the assessment of pain and function is often based on validated parameters (visual analog scales and/or self-questionnaires) but variable over time (during the day, depending on physical activity or between 2 medical visits).

Given these challenges, there is great interest in using low-cost wearable sensors to develop mobile tools to obtain functional data on patients.

Thanks to the contribution of an evaluation technique based on inertial sensors (X-SENS device), the objective is to better evaluate and understand the movement deficit of of knee OA subjects.

The investigators believe that the combination of clinical, biological, imaging and mobility parameters will allow us to identify prognostic factors for OA.

The hypothesis is that, thanks to the contribution of a technique based on inertial sensors (X-SENS), the investigators can better evaluate the movement deficit of knee OA subjects. The goal is to propose specific, rapid telekinetic biomarkers, allowing a better evaluation of functional improvements following therapeutic interventions, such as a total knee replacement.

Another hypothesis is to better understand the alterations in mobility of the knee OA subject by studying several parameters: contractile function of the quadriceps; changes in body composition and muscle volume; and biological functions of muscle fibers and joint tissue.

03

Conditions studied

  • Knee Osteoarthritis

Keywords

  • knee osteoarthritis
  • mobility
  • inertial sensors
  • sarcopenia
04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patient over 60 years old
  • Presence of unilateral knee osteoarthritis (Kellgren and Lawrence radiographic stage ≥ 3) in the femorotibial compartment and/or Iwano stage ≥2 in the femoropatellar compartment);
  • Average VAS (Visual Analogic Scale) pain on a reference joint (knee) > 40/100 during the past month.
  • Indication for prosthetic knee surgery (total knee replacement)
  • Failure of a well-conducted medical treatment (at least one prior infiltration with corticoids or hyaluronic acid or PRP (-rich plasma))

Exclusion criteria

Exclusion Criteria:

  • Presence of an inflammatory joint disease (rheumatoid arthritis, spondyloarthritis, microcrystalline pathology)
  • Presence of a post-traumatic gonarthrosis
  • Frontal deformity of the lower limb > 15
  • Preoperative flessum > 15° or preoperative knee mobility \< 90°
  • Neurological pathology
  • Spinal pathology that is painful or causes deformity (severe Cobb scoliosis > 20°)
  • History of trauma or surgery of the lower limbs in the last two years,
  • Presence of at least one lower limb prosthesis (total hip or ankle prosthesis)
  • Subject with a to MRI examination (pacemaker, neurosensory stimulators, cardiac defibrillator, cochlear implants, ferromagnetic ocular or cerebral foreign bodies...)
  • Subjects with a contraindication to DXA examination (coronary stent or metallic cardiac sutures, pacemaker or automatic defibrillator, obesity with a > 35kg/m2, insulin pump, weight over 200kgs)
  • Subject with a legal protection measure (guardianship, curatorship)
  • Subject under legal protection
  • Subject not affiliated to a social security system or not benefiting from such a system
  • Absence of informed written consent
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Platelets

Blood cells that help blood clot. Too few raises the risk of bleeding and bruising. A usual adult range is about 150–400 × 10⁹/L (150,000–400,000 per µL); each lab has its own reference range.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
20 participants (estimated)

Study arms

  • Experimental
    total knee replacement surgery group

    The study will be conducted in 4 visits: * a pre-inclusion visit during a routine care consultation where the patient will be informed about the study * a V1 inclusion visit (pre-surgery of the knee) during which informed consent, clinical examination, VAS, self-questionnaires, DXA, X-SENS sensor, MRI, isokinetism will be collected * a V2 visit during the operation, during which biological samples will be taken (muscle biopsy, collection of osteoarticular parts, and serum collection) * a V3 visit at 12 months with a clinical examination, EVA, self-questionnaires, DXA, isokinetics, X-SENS sensor, serum collection, and collection of adverse events.

    Device: X-sens sensor

Interventions

  • DeviceX-sens sensor

    the procedure will include: * 7 to 8 sensors (Foot, leg, thigh, pelvis and chest possibly). * 5 movements/exercises for the patients, each exercise performed 3 times except walking * Analysis of 20m walking cycle (normal speed, most natural arm movement, 4 return trips of 20m): * Climbing up and down stairs (using the public stairs of the rheumatology access department, 6 steps of 20 cm height, at normal speed, without using the handrail) * Getting up from a chair without the help of hands (start standing, then the patient sits, leans and stands up, feet together, without taking the feet off the floor, using one and the same chair for each patient with a height of 50 cm)

06

What researchers measure

Primary outcomes

  1. Changes in inertial parameters before and after total knee replacement (TKR)

    Angular measurements in the sagittal plane during flexion and extension of the knee at 2 different times (before/after TKR) during functional movements by specifying the flexion angle at foot contact, the peak flexion angle at the beginning of the swing phase, the peak extension angle during the swing phase. Measurements will be taken with Xsens sensors

    Time frame: between baseline and 12 months

Secondary outcomes

  1. percentage association of knee kinematics parameters with the pain VAS score at baseline

    evaluate the percentage of association between kinematic parameters and the pain VAS score. the kinematic parameters of the knee are measured via the Xsens sensors The VAS is patient self-assessment pain scale. A high score indicates severe pain (0 = absence of pain, 100 = severe pain)

    Time frame: at baseline

  2. percentage association of knee kinematics parameters with the pain VAS score at 12 months

    evaluate the percentage of association between kinematic parameters and the VAS score. the kinematic parameters of the knee are measured via the Xsens sensors The VAS is patient self-assessment pain scale. A high score indicates severe pain (0 = absence of pain, 100 = severe pain)

    Time frame: at 12 months

  3. percentage association of knee kinematics parameters with IPAQ score at baseline

    evaluate the percentage of association between kinematic parameters and the IPAQ (International Physical Activity Questionnaire) score the kinematic parameters of the knee are measured via the Xsens sensors IPAQ test allows us to estimate over the last 7 days the time spent doing physical activities (intense and moderate), the time spent walking and the time spent sitting. By multiplying the minutes of daily activity by an activity coefficient (3.3 for walking, 4 for intense physical activity and 8 for moderate), we have a score in MET/min/week.

    Time frame: at baseline

  4. percentage association of knee kinematics parameters with IPAQ score at 12 months

    evaluate the percentage of association between kinematic parameters and the IPAQ (International Physical Activity Questionnaire) score the kinematic parameters of the knee are measured via the Xsens sensors IPAQ test allows us to estimate over the last 7 days the time spent doing physical activities (intense and moderate), the time spent walking and the time spent sitting. By multiplying the minutes of daily activity by an activity coefficient (3.3 for walking, 4 for intense physical activity and 8 for moderate), we have a score in MET/min/week.

    Time frame: at 12 months

  5. percentage association of knee kinematics parameters with clinical parameters at baseline

    evaluate the percentage of association between kinematic parameters and the actimeter the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  6. percentage association of knee kinematics with clinical parameters at 12 months

    evaluate the percentage of association between kinematic parameters and the actimeter the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  7. percentage association of knee kinematics parameters with KOOS score at baseline

    evaluate the percentage of association between kinematic parameters and the KOOS (Knee Injury and Osteoarthritis Outcome Score) score KOOS test is a self-administered questionnaire that measures the patient's opinion of their knee health, symptoms and functionality. It contains 42 items divided into the categories of symptoms, pain, activities of daily living, sports and quality of life. The patient has 5 response modalities ranging from "not at all" to "a lot" and gives a score out of 100. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  8. percentage association of knee kinematics parameters with KOOS score at 12 months

    evaluate the percentage of association between kinematic parameters and the KOOS (Knee Injury and Osteoarthritis Outcome Score) score KOOS test is a self-administered questionnaire that measures the patient's opinion of their knee health, symptoms and functionality. It contains 42 items divided into the categories of symptoms, pain, activities of daily living, sports and quality of life. The patient has 5 response modalities ranging from "not at all" to "a lot" and gives a score out of 100. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  9. percentage association of knee kinematics parameters with pain detect score at baseline

    evaluate the percentage of association between kinematic parameters and the pain detect score pain DETECT is used to discriminate between neuropathic and nociceptive pain. It contains 9 questions: the first 7 deal with the assessment of pain from 0 (absent) to 5 (strongly noticed), question 8 deals with the evolution of pain (from -1 to 2), and the last one deals with the presence of radiating pain (2 points if yes, 0 if no). A score ≤ 12 indicates that the pain is unlikely to have a neuropathic component, whereas a score ≥ 19 suggests that the pain is likely to have a neuropathic component. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  10. percentage association of knee kinematics parameters with pain detect score at 12 months

    evaluate the percentage of association between kinematic parameters and the pain detect score pain DETECT is used to discriminate between neuropathic and nociceptive pain. It contains 9 questions: the first 7 deal with the assessment of pain from 0 (absent) to 5 (strongly noticed), question 8 deals with the evolution of pain (from -1 to 2), and the last one deals with the presence of radiating pain (2 points if yes, 0 if no). A score ≤ 12 indicates that the pain is unlikely to have a neuropathic component, whereas a score ≥ 19 suggests that the pain is likely to have a neuropathic component. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  11. percentage association of knee kinematics parameters with OASIS score at baseline

    evaluate the percentage of association between kinematic parameters and the OASIS (Overall Anxiety Severity and Impairment Scale) score OASIS assesses the patient's experience along 8 dimensions: sensory description, symptoms associated with arthrosis, pain rhythm, triggers, physical activity, mood, self-representation and finally general symptoms. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  12. percentage association of knee kinematics parameters with OASIS score at 12months

    evaluate the percentage of association between kinematic parameters and the OASIS (Overall Anxiety Severity and Impairment Scale) score OASIS assesses the patient's experience along 8 dimensions: sensory description, symptoms associated with arthrosis, pain rhythm, triggers, physical activity, mood, self-representation and finally general symptoms. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  13. percentage association of knee kinematics parameters with FJS-12 score at baseline

    evaluate the percentage of association between kinematic parameters and the FJS-12 (Forgotten Joint Score-12) score FJS-12 assesses the ability of patients to forget their TKP in activities of daily living. It contains 12 items, rated from 0 (no awareness of the knee) to 4 (permanently). The score varies from 0 (extremely annoying prosthesis) to 100 (low awareness of the joint/prosthesis). This score is very relevant since it allows the practitioner to evaluate the patient's feelings about the success of the operation. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  14. percentage association of knee kinematics parameters with FJS-12 score at 12 months

    evaluate the percentage of association between kinematic parameters and the FJS-12 (Forgotten Joint Score-12) score FJS-12 assesses the ability of patients to forget their TKP in activities of daily living. It contains 12 items, rated from 0 (no awareness of the knee) to 4 (permanently). The score varies from 0 (extremely annoying prosthesis) to 100 (low awareness of the joint/prosthesis). This score is very relevant since it allows the practitioner to evaluate the patient's feelings about the success of the operation. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at months

  15. percentage association of knee kinematics parameters with MNA score at baseline

    evaluate the percentage of association between kinematic parameters and the MNA (Mini Nutritional Assessment) score MNA is a 2-part questionnaire that aims to identify elderly people who are malnourished or at risk of malnutrition (from age 65). The first part is a 14-point screening score that assesses the patient's motor skills, weight loss, BMI and physical condition. If the patient has less than 11 points, he/she is invited to continue with the rest of the questionnaire, which looks at his/her eating habits, hydration, arm circumference, etc. Nutritional status is considered poor if the score is \< 17/30 and "at risk of malnutrition" if the score is between 17 and 23.5. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  16. percentage association of knee kinematics parameters with MNA score at 12 months

    evaluate the percentage of association between kinematic parameters and the MNA (Mini Nutritional Assessment) score MNA is a 2-part questionnaire that aims to identify elderly people who are malnourished or at risk of malnutrition (from age 65). The first part is a 14-point screening score that assesses the patient's motor skills, weight loss, BMI and physical condition. If the patient has less than 11 points, he/she is invited to continue with the rest of the questionnaire, which looks at his/her eating habits, hydration, arm circumference, etc. Nutritional status is considered poor if the score is \< 17/30 and "at risk of malnutrition" if the score is between 17 and 23.5. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  17. percentage association of knee kinematics parameters with SARC-F score at baseline

    evaluate the percentage of association between kinematic parameters and the SARC-F (Strength, assistance with walking, rising from a chair, climbing stairs, and falls) score SARC-F is for the early detection of sarcopenia. It contains 5 questions with 3 answer modalities concerning activities such as standing up from a chair or carrying a weight. Each question has 3 response modalities: "No difficulty - 0 points" "a little - 1 point" or "a lot, unable - 2 points". A score \> 4 indicates a risk of sarcopenia the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  18. percentage association of knee kinematics parameters with SARC-F score at 12 months

    evaluate the percentage of association between kinematic parameters and the SARC-F (Strength, assistance with walking, rising from a chair, climbing stairs, and falls) score SARC-F is for the early detection of sarcopenia. It contains 5 questions with 3 answer modalities concerning activities such as standing up from a chair or carrying a weight. Each question has 3 response modalities: "No difficulty - 0 points" "a little - 1 point" or "a lot, unable - 2 points". A score \> 4 indicates a risk of sarcopenia the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  19. percentage association of knee kinematics with contractile function of the quadriceps at baseline

    evaluate the percentage of association between kinematic parameters and contractile function of the quadriceps Measurement of isokinetic parameters on evaluation of the deficit on the healthy side/injured side with the ratio Quadriceps / Hamstrings the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  20. percentage association of knee kinematics with contractile function of the quadriceps at 12 months

    evaluate the percentage of association between kinematic parameters and contractile function of the quadriceps Measurement of isokinetic parameters on evaluation of the deficit on the healthy side/injured side with the ratio Quadriceps / Hamstrings the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  21. percentage association of knee kinematics parameters with body composition at baseline

    evaluate the percentage of association between kinematic parameters and body composition Measurement of total body composition: appendicular lean mass (sum of lean mass of all 4 limbs: ALM) / height²); percentage of lean mass, visceral fat and whole body fat. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  22. percentage association of knee kinematics parameters with body composition at at 12 months

    evaluate the percentage of association between kinematic parameters and body composition Measurement of total body composition: appendicular lean mass (sum of lean mass of all 4 limbs: ALM) / height²); percentage of lean mass, visceral fat and whole body fat. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at 12 months

  23. percentage association of knee kinematics parameters with muscle mass at baseline

    evaluate the percentage of association between kinematic parameters and muscle mass Measurement of muscle volume of both quadriceps and comparison of muscle changes between osteoarthritic and non-osteoarthritic knees. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  24. percentage association of knee kinematics parameters with the biological function of muscle and joint cells at baseline

    evaluate the percentage of association between kinematic parameters and the biological function of muscle and joint cells Measurement of the cross-sectional area of quadriceps muscle fibers. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  25. percentage association of knee kinematics parameters with the number and size of myoblasts at baseline

    evaluate the percentage of association between kinematic parameters and the biological function of muscle and joint cells Number and size of myoblasts obtained per satellite cell cultured on a longitudinal groove microstructured support. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  26. percentage association of knee kinematics parameters with the differentiation capacity of mesenchymal stromal cells at baseline

    evaluate the percentage of association between kinematic parameters and the biological function of muscle and joint cells Capacity of mesenchymal stromal cells (MSC) to differentiate into chondrocytes. the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

  27. percentage association of knee kinematics with the senescence of musculoskeletal tissues at baseline

    evaluate the percentage of association between kinematic parameters and the biological function of muscle and joint cells Measurement of the senescence of musculoskeletal tissues (chondrocytes, synoviocytes, adipocytes). the kinematic parameters of the knee are measured via the Xsens sensors

    Time frame: at baseline

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Mar 2023 (actual). Primary completion is estimated for Mar 2027, 48 months after the start.

Of 1,114 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's planned 48 months is above that.

Counting every sponsor, half of 1,253 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 2, 2022
First posted
Aug 4, 2022
StartActual
Mar 30, 2023
Primary completionEst.
Mar 2027
CompletionEst.
Mar 2027
Last update
Apr 14, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 14, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05488093
Responsible party
Sponsor
First posted
Aug 4, 2022
Start date
Mar 30, 2023
Primary completion
Mar 2027 (estimated)
Completion
Mar 2027 (estimated)
Last update
Apr 14, 2026

Study contacts

Yves-Marie PERS, MD-PhD
Contact
ym-pers@chu-montpellier.fr
04.67.33.72.31 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion